Daily Stock List
Kallo, Inc. (KALO)
StockBomb.com, StockRockandRoll, and StockLockandLoad reported this month on Kallo, Inc. (KALO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Kallo, Inc. is a medical information company with corporate headquarters in Markham, Ontario. The Company engages in the manufacturing and development of software that assists physicians and nurses to streamline patient information. All of their products provide secure medical document management and system maintenance to reduce costs. All of the Company’s solutions have been specifically designed for seamless integration with a customer’s existing processes, procedures, programs, and databases to maximize their efficiency.
Kallo’s software solution includes Electronic Medical Record software (EMR) and connectivity software that gathers medical information from various sources and deposits it into a single source as an electronic medical record for each patient. The Company’s software includes EMCURx. This software is seamlessly integrated with a customer’s existing software, while its independent server and database ensure 24/7 accessibility and security. EMCURx’ intuitive screens allow a user to effortlessly access information using any device connected to the Internet. EMCURx has global compatibility. It translates into any language and easily accommodates regional standards for prescription measurements, drug names, and follow-up care.
The Company’s medical device connectivity (MDC) connects any medical device to a customer’s clinical application. Its flexible, patient-centered design adapts to established clinical work processes and integrates with existing technologies. MDC automatically updates electronic medical records (EMRs) and gives a user immediate access to the data they need to treat their patients. MDC reduces charting errors, increases adoption of EMRs, recovers medical staff time and improves workflow. All of these results in improved patient care.
Kallo’s cloud-based, device agnostic Picture Archival and Communication System (PACS) allows instant, on-demand transfer and retrieval of patient X-rays, MRI scans, ultrasound, and other images across a universal platform. PACS is fully managed by Kallo.
In July, Kallo announced that the Government of Ghana extended an invitation to Kallo to visit Accra, Ghana on July 23, 2012 for final discussions for approval of distribution and operation of Kallo's Mobile Care Clinics. The Company’s Mobile Care Clinics allow physicians to provide mobile services to rural areas where people have difficulty traveling to receive care.
Kallo, Inc. (KALO), closed on Tuesday at $0.05, even with yesterday’s close. The average volume for the last 60 days is 18,445. The 52-week low/high is $0.01/$0.51.
Elite Pharmaceuticals, Inc. (ELTP)
SmarTrend Newsletters, GoldminePennyStocks, Greenbackers, and PennyTrader Publisher reported earlier on Elite Pharmaceuticals, Inc. (ELTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that lists on the OTC Bulletin Board. The Company’s dedication is to developing and commercializing oral controlled release product formulations and the manufacturing of generic pharmaceuticals. Elite Pharmaceuticals has four commercial products, with five additional products under review, pending approval by the Food and Drug Administration (FDA). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, New Jersey.
The Company’s strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry. Elite's lead pipeline products include abuse resistant opioids utilizing the Company’s patented proprietary technology, and a once-daily opioid. Additionally, Elite has partnered with Mikah Pharma to develop a new product, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the U.S. market and its territories.
For the fiscal year ended March 31, 2012, Elite incurred decreases in revenues and cash flows. These were the result of the removal of the Lodrane Extended Release products from the U.S. market, pursuant to a directive from the FDA which applied to approximately 500 products, including the Lodrane Extended Release Products. At the time of the FDA's directive, the Lodrane Extended Release Products comprised 97 percent of the Company’s revenues.
Most of Elite's revenues during this fiscal year are the result of new products launched and new revenue streams created during fiscal 2012. The new products, all launched during this fiscal year, are phentermine tablets and hydromorphone tablets undergoing distribution under license by TAGI Pharma and Lodrane D® capsules co-developed and sold by ECR Pharmaceuticals. Elite also initiated contract manufacturing of methadone tablets for ThePharmaNetwork this fiscal year. In addition, Elite now has two ANDAs pending approval with the FDA and two manufacturing transfers pending approval by the FDA.
Recently, Elite Pharmaceuticals announced results for the fiscal year ended March 31, 2012. Consolidated revenues were $2.4 million, a decrease of 43 percent over last year's revenues of $4.3 million. Consolidated loss from operations was $(2.0 million) for the 2012 fiscal year, compared with a loss from operations of $(0.9 million) in the prior year.
GAAP net loss, including non-cash expenses relating to the accounting treatment of preferred share and warrant derivatives was $(15.1 million), compared to a GAAP net loss of $(13.6 million) in the prior year. Basic and diluted loss per common share was $(0.06) on a weighted average 259.2 million common shares outstanding, this fiscal year, compared to a basic and diluted per common share of $(0.14) and a weighted average common shares outstanding of 100.0 million shares in the prior fiscal year.
Elite Pharmaceuticals, Inc. (ELTP), closed on Tuesday at $0.10, down 3.84%, on 379,696 volume with 43 trades. The average volume for the last 60 days is 1,037,774. The 52-week low/high is $0.06/$0.17.
Pacific North West Capital Corp. (PAWEF)
Stockhouse and FeedBlitz reported previously on Pacific North West Capital Corp. (PAWEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Pacific North West Capital Corp. is a mineral exploration company. Their philosophy is to be a project generator, explorer, and project operator, in order to option-joint venture their projects through to production. Founded in 1996, Pacific North West Capital has their corporate headquarters in Vancouver, British Columbia. The Company’s shares also list on the Toronto Stock Exchange under the symbol "PFN".
Pacific North West Capital focuses on the discovery, exploration and development of platinum group metal (PGM) and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is their 100 percent owned River Valley PGM Project in the Sudbury region of northern Ontario. In addition, the Company has PGM and nickel-copper projects and properties in northwest Ontario, Saskatchewan, and Alaska. They continue to evaluate PGM and nickel-copper properties and projects in North America for potential acquisition opportunities.
In January 2011, Pacific North West Capital successfully negotiated the 100 percent acquisition of the River Valley PGM Project from Anglo Platinum Ltd. The River Valley Project is one of the largest undeveloped primary PGM Projects in North America. The project has excellent infrastructure support. It is 100 km from the city of Sudbury, Ontario, Canada's largest nickel-copper-PGM mining and metal recovery center.
In July of this year, Pacific North West Capital announced their acceptance of a proposal from SGS Canada, Inc. for metallurgical testing on the River Valley platinum group metal (PGM) deposit. On May 1, 2012 the Company announced a new NI43-101 compliant mineral resource estimation. The estimated Measured + Indicated mineral resources at a cut-off grade of 0.80 g/t PdEq total 91,339,500 tonnes grading 0.84 g/t Pd+Pt+Au, 0.06 percent copper and 0.02 percent nickel (1.38 g/t PdEq). The Inferred resources total 35,911,000 tonnes grading 0.53 g/t Pd+Pt+Au, 0.06 percent copper and 0.03 percent nickel (1.07 g/t PdEq).
Pacific North West Capital Corp. (PAWEF), closed on Tuesday at $0.07, even with yesterday’s close. The average volume for the last 60 days is 10,493. The 52-week low/high is $0.04/$0.31.
Applied Nanotech Holdings, Inc. (APNT)
RedChip, SmallCapVoice, and FeedBlitz reported earlier on Applied Nanotech Holdings, Inc. (APNT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Applied Nanotech Holdings, Inc. is a global leader in nanotechnology. The Company focuses on solving problems at the molecular level, and commercializing the results of their research. Applied Nanotech has more than 300 patents or patents pending. The Company has their headquarters in Austin, Texas. They were founded in 1989, and they went public in 1993.
Applied Nanotech’s team of PhD-level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The Company’s business model is to sell products and license patents and technology to partners that will manufacture and distribute products using the technology.
The Company has organized their efforts into five divisions. These are Nanomaterials, Nanoelectronics, Nanosensors, Nanoecology, and their legacy business, CNT Electron Emission. Nanomaterials involve enhancing the mechanical and physical properties of materials for improved products. Nanoelectronics involve exploiting nanoscale phenomena for emerging electronics applications. Nanosensors involve developing sensor, sensor networks and sensor applications for consumer, industrial, defense and medical applications.
Nanoecology involves developing nanotechnology-based products for a healthier and greener environment. CNT Electron Emission involves developing new applications of electron emission from carbon nanotubes. Currently, Applied Nanotech has established the following business units: CarbAl™ thermal management materials; Technical Inks Printing Solution (TIPS); CNT reinforced composites, and Life Science Sensors - Breath analysis.
Last week, Applied Nanotech Holdings introduced a new copper ink material based on micron copper particles for low-cost direct printing of electronic circuits for mobile devices, solar cells, display devices, and more. The new microcopper ink material joins the Company's award-winning nanocopper ink, which won an R&D 100 award from R&D Magazine in 2010. The novel copper ink is specially designed to replace expensive silver-based conductors for rapidly developing applications in the printed electronics industry.
Dr. James Novak, Director of the Nanoelectronics Division, said, "Microcopper inks fill a need for lower-cost conductive materials used for applications such as smart cards, RFID antennas, touchscreens and sensors in smart phones, just to name a few. Furthermore, the microcopper ink retains all key advantages of nanomaterial-based copper ink, such as low-temperature sintering and ease of application."
Applied Nanotech Holdings, Inc. (APNT), closed on Tuesday at $0.20, up 16.47%, on 89,700 volume with 16 trades. The average volume for the last 60 days is 45,181. The 52-week low/high is $0.17/$0.40.
Royal Energy Resources, Inc. (ROYE)
InvestmentDailyNews, SmallCapSociety, Pumps and Dumps, Stock Exploder, Best of OTC, Prof. Stocks, Newsworthy Team, 365 News Media Team, and StockMister reported earlier on Royal Energy Resources, Inc. (ROYE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Royal Energy Resources, Inc. is a development stage company whose shares trade on the OTC Bulletin Board. The Company focuses on acquiring and developing mineral projects. Currently, Royal Energy Resources is pursuing gold, silver, copper and rare earth metals mining concessions in Romania, Bulgaria and Canada and mining leases in the United States. Royal Energy Resources has their corporate headquarters in Brooklyn, New York.
If successful in their mineral mining concessions pursuits, the Company plans to concentrate their efforts to develop these properties. At May 31, 2012, Royal Energy Resources held the lease for 2,100 acres of rare earth and precious metals leases in Crook County, Wyoming. There are leases for 1,280 acres pending. The rare earth and precious metals leases are approximately 5-15 miles from Bear Lodge Mountain near Sundance, Wyoming. The U.S. Geological Survey has studied Bear Lodge Mountain extensively (USGS Prof. Paper #1049-D). They have estimated it contains one of the largest deposits of disseminated rare earth elements in North America.
Moreover, Royal Energy Resources holds the lease for uranium rights on approximately 960 acres in Laramie County, Wyoming as of May 31, 2012 and August 31, 2011, respectively. The uranium rights are on a trend approximately 25-30 miles from a proposed uranium mine in Weld County, Colorado, which was estimated to have uranium reserves valued at more than $500 million.
Concerning undeveloped leaseholds not being amortized, the Company has been the successful bidder in United States Government auctions to purchase certain oil and gas lease rights. The oil and gas leases currently consist of approximately 1,630 acres in Weston, Goshen, Niobrara, Converse, Campbell, Freemont, Laramie, Sublette, and Platt Counties, Wyoming as of May 31, 2012 and August 31, 2011, respectively.
As of May 31, 2012, Royal Energy Resources had collected approximately $72,000 from sales of leases and royalty interests. On May 14, 2012, they received an offer to purchase their interest in a 320 acre lease in Converse County, Wyoming for $17,000. The sale is subject to due diligence and was scheduled to close by August 1, 2012, with the Company retaining a 1 percent royalty interest.
Royal Energy Resources is negotiating with energy companies to develop the potential resources that may be contained in these properties. The Company has entered into agreements and then sold, by assignment, the rights, title and interest in certain of these leases and retained an over-riding royalty interest.
Royal Energy Resources, Inc. (ROYE), closed on Tuesday at $0.005, up 22.22%, on 532,515 volume with 298 trades. The average volume for the last 60 days is 34,377. The 52-week low/high is $0.001/$0.02.
Canaco Resources, Inc. (CAN.V)
CRWEPicks and Lebed.biz reported previously on Canaco Resources, Inc. (CAN.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Trading on the TSX Venture Exchange, Canaco Resources, Inc. is a Vancouver, British Columbia-based mineral exploration company. Canaco is focusing on advanced exploration projects in Africa. The Company has $95 million in cash and no debt. The Company’s key asset is the Handeni gold project in Tanzania, which the Company discovered in 2009.
Canaco has developed a partnership with SinoTech (Hong Kong) Corp. Ltd., a subsidiary of Sinotech Minerals Exploration Co., Ltd., a major Chinese exploration and mine development company. Sinotech has mineral exploration projects in mainland China and more than 10 countries around the world.
The Handeni property is in the Tanga region of northeastern Tanzania. It is 160 kilometers northwest of Dar es Salaam and 110 kilometers west-southwest of the port city of Tanga. The Handeni property covers an area of approximately 97 square kilometers. It consists of two key tenured blocks known as Handeni and Magambazi. Gold was discovered by locals in the Magambazi area in 2003. This spurred a gold rush with intense alluvial and hard rock mining. Canaco Resources acquired the Handeni property in 2007; the Company commenced drilling at Magambazi in 2009.
In December 2011, the Company commissioned an initial mineral resource estimate for the mineralized portion of the Magambazi area. The results of this work were announced on May 15, 2012, reporting an initial mineral resource estimate of 15.2 million tonnes grading 1.48 grams per tonne gold and containing 721,300 ounces in the indicated category, as well as 6.7 million tonnes grading 1.36 grams per tonne gold and containing 292,400 ounces in the inferred category. A cut-off grade of 0.5 grams per tonne was selected as the resource base case, considering extraction by conventional surface mining and mineral processing methods.
Last week, Canaco Resources announced that they entered into a Memorandum of Understanding (MOU) with an arm's length third party, a Chinese gold producer, to create a joint venture (JV) to develop the Company’s Magambazi project in Tanzania. Under the terms of the MOU, Canaco and the Chinese gold company will form a JV to develop and explore the Handeni project. Canaco's initial contribution to the JV will be the Handeni property, including the Magambazi project and all rights and obligations within the Handeni property.
The value of Canaco's initial contribution will be determined by an independent valuation firm retained by both parties. The Chinese gold company may earn up to a 55 percent interest in the JV by funding 100 percent of the costs of the ongoing operations of the JV until the earn-in is complete.
Canaco Resources, Inc. (CAN.V), closed on Tuesday at $0.37, down 7.50%, on 1,219,361 volume. The 52-week low/high is $0.27/$3.68.
MDN, Inc. (MDN.TO)
Today we are reporting on MDN, Inc. (MDN.TO), here at the QualityStocks Daily Newsletter.
Listed on the Toronto Stock Exchange, MDN, Inc. is a mining exploration and development company exploring and developing projects in Quebec and Tanzania. The Company is also active in the search for new business opportunities that can increase shareholder value. Founded in 1954, MDN is based in Montreal, Quebec. The Company was formerly known as Northern Mining Explorations Ltd. They changed their name to MDN, Inc. in May of 2007.
The Company has a 30 percent participating interest in the Tulawaka gold mine. In addition, MDN is the operator and owner of a majority interest in mineral licenses totaling 757 km2 in the vicinity of the Tulawaka mine. MDN also owns a 72.5 percent interest in Crevier Minerals, Inc., which owns an NI 43-101 niobium-tantalum resource in the Lac-Saint-Jean area of Quebec. MDN has an option to increase their equity participation in Crevier Minerals to a maximum of 87.5 percent.
In June, MDN reported that Tuesday, June 12, 2012 marked the start of a drilling program at the Company’s wholly-owned Nikonga property in Tanzania. The goal of the program is to test the strike and depth extensions of the gold-bearing intersections returned earlier in the year by holes NKD-02 and NKRC-14. The current diamond drilling program consists of 8 to 10 holes for a total of 1,300 meters. The results of drilling done earlier this year revealed two subparallel structures with high-grade gold, associated with a gold soil anomaly nearly two kilometers long.
In parallel with this drilling program on Nikonga, mapping and soil sampling have been underway since April 2012 on new ground acquired by MDN to the east of the Ikungu property. The Ikungu mineralized zone has been outlined over a strike length of more than two kilometers and to a depth of 300 meters.
Last month, MDN reported to their shareholders that African Barrick Gold plc (ABG), the project operator at the Tulawaka gold mine in Tanzania, in which MDN has a 30 percent participating interest, announced their second quarter and first half operational results. Tulawaka continued to perform in line with expectations during the reporting period, as it transitioned to a solely underground operation and the process plant began to operate under a batch processing method. This led to an expected reduction in production and associated higher cost.
An increase in the grade profile is expected during the second half of 2012. This should help increase production levels. Tulawaka drilling continues to be successful. The operator has been able to replace reserves mined in the first half of the year, consequently extending the mine life into mid 2013. Deeper drilling continues to encounter continuity of mineralization at depth. ABG is targeting further extensions of the mine life.
MDN, Inc. (MDN.TO), closed on Tuesday at $0.20, up 2.56%, on 54,666 volume. The 52-week low/high is $0.19/$0.33.
Mecox Lane Ltd. (MCOX)
StreetInsider, Stock Fortune Teller, MadPennyStocks, StockRich, CoolPennyStocks, HotOTC, PennyStockVille, BullRally, StockEgg, PennyInvest, and Greenbackers reported previously on Mecox Lane Ltd. (MCOX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Mecox Lane Ltd. operates one of China's leading online platforms for apparel and accessories as measured by revenues in 2011. They offer an extensive selection of fashion products by way of their www.m18.com e-commerce website and physical store network. Founded in 1996, Mecox Lane has their corporate headquarters in Shanghai, the People’s Republic of China (PRC). The Company’s shares list on the NASDAQ Global Select Market.
As of December 31, 2011, the Company’s store network consisted of 400 stores, including 282 franchised stores and 118 directly operated stores in 146 cities. As of December 31, 2011, Mecox Lane had a total of 3,586 employees.
Mecox Lane’s product offerings include apparel and accessories, home products, beauty and healthcare products and other products, under the Company's own proprietary brands, such as Euromoda and Rampage, as well as other selected third-party brands. These third-party brands include established international and Chinese brands in addition to independent and emerging brands.
The Company offers women’s T-shirts, sweaters, jeans, dresses, outerwear, purses, and shoes, as well as children’s apparel, men’s apparel, and maternity apparel. In addition, Mecox Lane provides home furnishings and other small household appliances; beauty and health products, such as skin care, fragrance, cosmetics, and other personal care products; and pet-related and other products, and office accessories. Furthermore, Mecox Lane engages in the telephonic sale of garments, accessories, and other products; the wholesale and retail of garments; and the provision of software development and information technology support services.
In May, Mecox Lane announced their unaudited financial results for the first quarter ended March 31, 2012. Internet platform net revenues decreased 35.1 percent year over year to $17.1 million, compared to $26.3 million in the first quarter of 2011. Net revenues decreased 22.8 percent year over year to $37.1 million, compared to $48.1 million in the first quarter of 2011.
Gross profit margin increased 2.1 percent year over year to 38.2 percent from 36.1 percent in the first quarter of 2011. Gross profit decreased 18.4 percent year over year to $14.2 million from $17.4 million in the first quarter of 2011. Net loss was $4.2 million, compared to a net loss of $3.9 million in the first quarter of 2011.
Mecox Lane Ltd. (MCOX), closed on Tuesday at $0.89, down 4.90%, on 6,926 volume with 17 trades. The average volume for the last 60 days is 40,710. The 52-week low/high is $0.61/$2.40.
Skinny Nutritional Corp. (SKNY)
The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.006, up 5.26%, on 2,461,287 volume with 32 trades. The stock’s average daily volume over the past 60 days is 2,782,884, and its 52-week low/high is $0.005/$0.057.
Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.
The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.
The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.
Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer
Skinny Nutritional Corp. Blog
Skinny Nutritional Corp. News:
A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration
Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally
Skinny Nutritional Corp. Enters Distribution Agreement With Michigan-Based D&B Grocers Wholesale, Inc.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.77, up 1.14%, on 800 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,497, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Announces New Channel Sales Partnership With RJ Young
GlobalWise Accepted as Member of Prestigious Organization Technology United
GlobalWise CEO to Be Featured Speaker at World Expo 2012 Conference
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.50, down 0.66%, on 7,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 7,000, and its 52-week low/high is $1.10/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Enters Final Stage of Negotiations for African Concession
Duma Energy Provides Third Quarter Results and Demonstrates Positive Earnings
Duma Energy Announces New Trading Symbol "DUMA"
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.301, off by 2.90%, on 63,570 volume with 16 trades. The stock’s average daily volume over the past 60 days is 12,327, and its 52-week low/high is $0.21/$1.00.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders
International Stem Cell Corporation Featured in Stem Cell Technology's Bright Future Article on Seeking Alpha
International Stem Cell Corporation Reports Reaching Milestone in Its Cornea Program
Company announces successful launch of it first franchise, “Station 1″
Fireman’s Contractors, Inc., a commercial contractor for the pavement maintenance and parking lot maintenance industry, today announced the launch of its first Firemans Contractors’ franchise, “Station 1,” in the Dallas-Fort Worth Metroplex. The station began operations July 1, followed by a ribbon cutting ceremony July 14.
“It’s an exciting time for our company as we are having tremendous interest shown by new potential franchisees. Launching of our first franchise has bred excitement and helped expose our franchise opportunity to other quality individuals and entrepreneurs. Mr. Fred Hermosillo, who has almost 20 years of experience in the pavement industry, seized the opportunity to own the first franchise and we both are looking forward to Station 1 being a great success,” Renee Gilmore, CEO of Firemans Contractors, stated in the press release.
Fireman’s Contractors is a member of the International Franchise Association (IFA), and a partner in the veterans’ financial incentives program, the VetFran Initiative. Fireman’s Contractors launched its first franchise development program to expand market share through franchise operations.
The company offers its new franchisees representation at the AATC – AAGD Business Exchange Trade Show, which attracts more than 200 executives from more than 50 property management companies, providing networking and discussion opportunities.
“Since last year’s attendance at the AATC-AAGD Business Exchange, Fireman’s not only gained a lot of new customers, but repeat business is up from 36% to 60% this fiscal year,” Gilmore stated.
For more information visit: www.FiremansContractors.com
Chimera Energy has a rapidly growing portfolio of energy technology products focused on profiting from the current domestic shale oil boom, like their high quality polycrystalline diamond cutters (largely used in oilfield/geological drill bit manufacturing) and their revolutionary new, all-weather, non-pollutive fracking alternative, for which the company executed a purchase order today with America West Drilling Supply, covering a key component known as the casing perforator.
This non-hydraulic extraction method developed by the company in China can handle extraction in areas too cold for fracking (due to the required water freezing), yet retains a comparable 65% production increase (if not better than fracking in some cases) and does so with zero impact to ground water quality, the major environmental concern in fracking operations. Using extreme heat produced by oxide exothermic reactions and ultra expansive evaporates, the same seam-splitting capabilities delivered by established fracking technologies is now possible without all the toxic chemicals (many of which are carcinogens) that eventually can end up in the water table.
The actual process works a lot like an ultra high-temp pressure cooker and the pumice-like material then acts as a kind of stent, keeping the fissures open for flow. The casing perforator is an essential part of the overall system and as CHMR moves towards a public showcasing of the new technology, as well as mass production, relicensing, and eventual sales, the system placed into service using the announced perforator will serve to springboard that patenting process handsomely. Chimera has an insanely powerful system here that could transform the face of the global shale boom and investors are paying close attention as the company is clearly in a position to shave a considerable slice off the huge pie currently dominated by other sector operators like Halliburton and Schlumberger.
It shouldn’t be hard to take a big slice either; this technology has the potential to deliver the same productivity while alleviating the growing concern from the public and governments about drinking water contamination linked to hydraulic fracturing. The technology will give early adopters a considerable momentum advantage on the permitting side and immediate logistical advantage due to improved efficiency.
Chimera has taken care to select a specific perforator for the system which, because it is pneumatically operated and does not require water or toxic chemicals to perform (in addition to blasting or ballistics), accentuates the already environmentally friendly design quite well. As one of the fundamental pieces falls into place for the CHMR design, shareholders and management alike are growing increasingly excited about the true commercialization potential of the system, as an eager market which is in full swing is practically aching for just this kind of solution. Non-hydraulic extraction is cheaper, cleaner, and can even be more effective than fracking, thus the clamor from operators, especially those in cold climates where the technology is like a godsend, will be significant.
For more information on this revolutionary new fracking alternative, or to stay up to date with the latest developments regarding the system, please visit the Chimera Energy Corp. website at: www.ChimeraEnergyUSA.com
Smith Micro Software, Inc. Productivity and Graphics Group, a producer of award-winning software that inspires consumer creativity and enables efficiency, today announced that it will be presenting impressive new features and special partnership information regarding its Poser ® 3D character animation solution August 5th through the 9th at SIGGRAPH 2012 at the Los Angeles Convention Center.
The Smith Micro Booth (#1130) will be hosting an exclusive sneak-peek of the forthcoming Reality 3. Pose Service Release 3 (SR3), featuring a GoZ™ plug-in for ZBrush, will also be available for viewing at SIGGRAPH. Furthermore, attendees will get a unique opportunity to preview the upcoming fourth edition of the popular Miki figure and the brand new Tyler GND character. Both highly anticipated items are the creation of Poser artist Blackhearted.
“For 18 years Poser has dominated the market as the standard for easy to use 3D characters for illustrators, graphic designers and animators – and SIGGRAPH has been a pivotal part of our release cycle,” said Steve Cooper, Senior Product Manager for Smith Micro Software Inc. “We announced our hugely successful Poser Pro 2012 version at SIGGRAPH last year and this year we have three major releases that will thrill our loyal base of more than 500,000 dedicated Poser artists.”
A list of notable Smith Micro’s Graphics products is presented below:
– NEW – MotionArtist(R) – Digital comic and interactive graphic novel creation. Bridging the gap between your comics and your readers. More info about MotionArtist
– Anime Studio(R) – Cutting-edge tools and techniques to produce popular styles of animated 2D movies, cartoons and cutout animations. More info about Anime Studio
– Poser(R) – The world’s most complete solution for creating art and animation using 3D characters, used by beginning and experienced artists alike. More info about Poser
– Manga Studio(R) – The most popular comic and manga creation software in the industry featuring powerful drawing and coloring tools. More info about Manga Studio For further information, please visit www.smithmicro.com
Company looks to advance polymer technologies as it meets key milestones set by Department of Defense’s Defense Advanced Research Projects Agency (DARPA) program.
CytoSorbents Corp., a company using blood purification technology to treat life-threatening illnesses, today announced that it has received from DARPA a technology development contract worth up to $3.8 million as part of its Dialysis-Like Therapeutics (DLT) program to treat sepsis, an often fatal condition caused by microorganisms or toxins in the tissue or bloodstream.
DARPA, an agency of the U.S. Department of Defense, is funding CytoSorbents’ development of a portable, artificially intelligent blood purification system capable of detecting and removing substances that can contribute to sepsis, including cytokines, toxins, biowarfare agents, pathogens, and activated cells.
Per the new development contract, CytoSorbents will receive $1.5 million in funding designated for the first of five years, based upon the satisfactory achievement of pre-determined milestones.
“We are delighted to officially begin working with DARPA on this exciting project and are honored to have had our unique core blood purification technology selected for funding. We are one of the industry leaders in the area of blood purification to treat sepsis and other critical care illnesses, with our first-in-class CytoSorb cytokine filter currently approved and commercialized in the European Union,” Dr. Phillip Chan, CEO, stated in the press release.
“That being said, under this DARPA program, we are looking to significantly advance our polymer technologies to not only remove cytokines, but also a wide variety of toxins, and do so with little to no anti-coagulation in both high flow and microfluidic systems. …”
Dr. Chan praised CytoSorbents’ technology and voiced assurance that the company can meet DARPA’s requirements.
“Because of the maturity of our technology, we are confident in our ability to meet DARPA’s timetable for technology development and strict performance metrics. Over the past several months, we have also collaborated with some of the leading potential systems integrators, to include our technologies into their integration proposals, under a separately funded DARPA DLT solicitation. The role of the systems integrator is to put together the best detection, separation and predictive modeling technologies into a single blood purification system and guide it to human clinical trials within 4 to 5 years. These partnerships are mutually beneficial and will help to contribute to the success of the overall program,” he stated.
There are currently no approved therapies to treat sepsis in the U.S. or in the EU.
For more information visit www.cytosorbents.com
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News